Clipping Board » Medical Myths ─ The truth about healthcare is often different from what you intuitively think.
2006-2-6
At the National Science and Technology Conference, Professor Wu Mengchao, a renowned hepatobiliary surgery expert from the Second Military Medical University of the People's Liberation Army, who received the highest award, spoke about liver cancer during the meeting. He mentioned that due to the lack of sensitive and specific early diagnostic methods, most liver cancer cases are clinically detected at an advanced stage. The overall treatment efficacy is poor, and the mortality rate is high, earning it the title "King of Cancers." According to the World Health Organization, there are 1 to 1.5 million new cases of liver cancer globally each year. Because China is a country with a high prevalence of hepatitis, and due to weak public health and health awareness, over 45% of the world's liver cancer cases occur in China.
Since the 1970s, with the application of alpha-fetoprotein, the gradual introduction of modern imaging diagnostic technologies such as B-ultrasound and CT into clinical practice, and the widespread use of digital subtraction angiography, spiral CT, and B-ultrasound-guided needle biopsy, over 98% of cases in high-risk groups—men aged 35 to 60 with a history of hepatitis or positive hepatitis serological markers—can be definitively diagnosed. In terms of surgical treatment, the reoperation for recurrent liver cancer initiated in China in the 1980s, as well as the treatment of unresectable large liver cancers followed by second-stage resection after tumor shrinkage, represents another major breakthrough in liver cancer surgery. However, he pointed out that with the accelerating modernization of traditional Chinese medicine (TCM), the use of TCM in cancer treatment has gained increasing recognition in the medical community. The significant role of TCM in cancer treatment has also contributed to China's high five-year survival rate for liver cancer.
Professor Wu believes that combining Chinese and Western medicine in the treatment of liver cancer can effectively prevent recurrence and metastasis. From the current perspective of Western medicine, there is a focus on the local area while neglecting the whole body, whereas TCM emphasizes the whole body. Combining the two approaches creates a complete "person." This is a unique feature of Chinese treatment, and the integration of Chinese and Western medicine will undoubtedly improve efficacy.
Professor Wu highly praised the achievements of President Zheng Weida of Beijing Weida TCM Cancer Hospital in using the "Four-in-One" therapy to treat tumors. He believes that the combination of psychological therapy, medication therapy, physical therapy, and dietary therapy is crucial for cancer rehabilitation. Particularly, the core of President Zheng Weida's "Four-in-One" therapy—the medication therapy part—uses the Cidan series of anti-cancer drugs and tailors personalized treatment plans based on different patients, disease types, and treatment stages. This ensures the specificity of the treatment plan, thereby achieving effective treatment outcomes. It fully embodies the TCM principles of syndrome differentiation and disease differentiation, highlighting the holistic approach to cancer treatment.
Source: http://www. takungpao. com/ news/ 06/ 02/ 06/ GY- 520480. htm
Previous topicNext topic
Integrated Chinese and Western Medicine Effectively Prevents Cancer Metastasis
At the National Science and Technology Conference, Professor Wu Mengchao, a renowned hepatobiliary surgery expert from the Second Military Medical University of the People's Liberation Army, who received the highest award, spoke about liver cancer during the meeting. He mentioned that due to the lack of sensitive and specific early diagnostic methods, most liver cancer cases are clinically detected at an advanced stage. The overall treatment efficacy is poor, and the mortality rate is high, earning it the title "King of Cancers." According to the World Health Organization, there are 1 to 1.5 million new cases of liver cancer globally each year. Because China is a country with a high prevalence of hepatitis, and due to weak public health and health awareness, over 45% of the world's liver cancer cases occur in China.
Since the 1970s, with the application of alpha-fetoprotein, the gradual introduction of modern imaging diagnostic technologies such as B-ultrasound and CT into clinical practice, and the widespread use of digital subtraction angiography, spiral CT, and B-ultrasound-guided needle biopsy, over 98% of cases in high-risk groups—men aged 35 to 60 with a history of hepatitis or positive hepatitis serological markers—can be definitively diagnosed. In terms of surgical treatment, the reoperation for recurrent liver cancer initiated in China in the 1980s, as well as the treatment of unresectable large liver cancers followed by second-stage resection after tumor shrinkage, represents another major breakthrough in liver cancer surgery. However, he pointed out that with the accelerating modernization of traditional Chinese medicine (TCM), the use of TCM in cancer treatment has gained increasing recognition in the medical community. The significant role of TCM in cancer treatment has also contributed to China's high five-year survival rate for liver cancer.
Professor Wu believes that combining Chinese and Western medicine in the treatment of liver cancer can effectively prevent recurrence and metastasis. From the current perspective of Western medicine, there is a focus on the local area while neglecting the whole body, whereas TCM emphasizes the whole body. Combining the two approaches creates a complete "person." This is a unique feature of Chinese treatment, and the integration of Chinese and Western medicine will undoubtedly improve efficacy.
Professor Wu highly praised the achievements of President Zheng Weida of Beijing Weida TCM Cancer Hospital in using the "Four-in-One" therapy to treat tumors. He believes that the combination of psychological therapy, medication therapy, physical therapy, and dietary therapy is crucial for cancer rehabilitation. Particularly, the core of President Zheng Weida's "Four-in-One" therapy—the medication therapy part—uses the Cidan series of anti-cancer drugs and tailors personalized treatment plans based on different patients, disease types, and treatment stages. This ensures the specificity of the treatment plan, thereby achieving effective treatment outcomes. It fully embodies the TCM principles of syndrome differentiation and disease differentiation, highlighting the holistic approach to cancer treatment.
Source: http://www. takungpao. com/ news/ 06/ 02/ 06/ GY- 520480. htm